Article Details

FDA Grants Vitality Biopharma Orphan Drug Designation for VBX-100 Prodrug

Retrieved on: 2021-08-10 12:56:15

Tags for this article:

Click the tags to see associated articles and topics

FDA Grants Vitality Biopharma Orphan Drug Designation for VBX-100 Prodrug. View article details on hiswai:

Excerpt

10, 2021 (GLOBE NEWSWIRE) -- Vitality Biopharma, Inc. (OTC: VBIO) (“Vitality” or the “Company”), an innovation-driven drug development company ...

Article found on: www.globenewswire.com

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up